> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Weiner Moves to Foreign Inspections Office
- URL: https://www.fdaweb.com/weiner-moves-to-foreign-inspections-office/
- Published: 2024-03-27T12:00:00.000Z
- Updated: 2026-09-14T14:26:41.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5156644

FDA Office of Combination Products (OCP) associate director for policy **John Weiner** has been promoted to Office of Global Operations director, where he will oversee the agency’s foreign inspection offices, as well as its international policy advisors, who are responsible for bilateral and regional engagement. At OCP, FDA says Weiner was a principal architect of the combination products regulatory program — “leveraging the regulatory programs for drugs, devices, and biological products and ensuring appropriate coordination across the FDA throughout the regulatory life cycle from investigation to premarket review, to marketing, manufacture, and postmarket change management.”

Earlier at FDA, he was an associate chief counsel, focusing on drug regulation and related innovation and competition issues, and on crosscutting topics including the use of nanotechnology — briefly serving as the policy lead for that issue. Weiner also previously served as FDA’s liaison to the Office of the United States Trade Representative and addressed issues relating to pharmaceutical trade and competition, while participating in multiple rounds of bilateral and regional trade negotiations as a technical advisor.

Weiner received his law degree from Columbia University School of Law.